Finch Therapeutics Group, Inc.
FNCHDelisted Oct 31, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001733257
Finch Therapeutics Group, Inc. was delisted on Oct 31, 2024; its insiders filed their last Form 4 on Jun 10, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Finch Therapeutics Group, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- 0 vs. Q3 2023
- Shares held
- 209.2K
- +11.2K (+5.7%) vs. Q3 2023
- Total value
- $754.7K
- −$378.0K (−33.4%) vs. Q3 2023
- New holders
- 3
- 2 more added
- Sold out
- 3
- 0 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FNCH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 1 | $29.1K |
| Q1 2024 | 11 | $338.2K |
| Q4 2023 | 17 | $754.7K |
| Q3 2023 | 18 | $1.37M |
| Q2 2023 | 17 | $2.16M |
| Q1 2023 | 33 | $3.75M |
| Q4 2022 | 40 | $4.60M |
| Q3 2022 | 43 | $16.8M |
| Q2 2022 | 47 | $28.0M |
| Q1 2022 | 53 | $53.1M |
| Q4 2021 | 51 | $115.0M |
| Q3 2021 | 45 | $106.8M |
| Q2 2021 | 46 | $77.2M |
| Q1 2021 | 36 | $108.9M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Finch Therapeutics Group, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 27 | $0 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 3 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2 | $7 | 0.00% | 00.0% | Unchanged |
| Moisand Fitzgerald Tamayo, LLC | 3 | $11 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 6 | $22 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 12 | $43 | 0.00% | +12 | New |
| Morgan Stanley | 123 | $444 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 141 | $509 | 0.00% | +141 | New |
| BlackRock Inc. | 341 | $1.23K | 0.00% | 00.0% | Unchanged |
| Bleichroeder LP | 971 | $3.50K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,626 | $9.48K | 0.00% | +2,187+498.2% | Added |
| Ikarian Capital, LLC | 6,892 | $24.9K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 11,746 | $42.0K | 0.00% | +11,746 | New |
| Lake Street Advisors Group, LLC | 21,206 | $76.6K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 38,764 | $139.9K | 0.00% | +2,825+7.9% | Added |
| Susquehanna International Group, LLP | 59,028 | $213.1K | 0.00% | 00.0% | Unchanged |
| Baupost Group LLCSuperinvestorBaupost Group | 67,296 | $243.0K | 0.01% | 00.0% | Unchanged |
| MSD Partners, L.P. | 0 | $0 | 0.00% | −5,113−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −533−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| Avenir Management Company, LLC | – | – | – | – | Not filed |